Research dealing with hormones/growth factors in milk has progressed rapidly during the last 10 yr from their identification in milk to their regulation of various functions in the maternal organism and in the neonate. Many hormones, growth factors, and bioactive substances present in the maternal organism are present in colostrum and milk, often exceeding concentrations that occur in maternal plasma. Some appear in milk in different, sometimes multiple, forms from that found in maternal serum, reflecting to some extent synthesis and posttranslational processing by mammary tissue. Recent research has indicated that many milk hormones/growth factors survive the environment of the gut of the neonate, become absorbed into the neonatal circulation, and exert important functions in the neonate.

Bovine IgG(1) is thought to be specifically transported by a process of transcytosis across the mammary epithelial cells during colostrogenesis. Mammary IgG(1) appearance in cow colostrum has typically been reported as a concentration and shows IgG(1) concentration to be extremely variable because of animal variation, colostrum milking time, and water dilution effects. To identify animal IgG(1) transfer capacity and separate it from the other effects, our objective was to determine first colostrum IgG(1) total mass. We collected 214 samples of totally milked first colostrum with recorded colostrum weights from 11 Pennsylvania dairy farms that participated in Pennsylvania Dairy Herd Improvement Association, analyzed colostrum for IgG(1) by ELISA, and calculated total IgG(1) mass. Median and mean concentrations of IgG(1) were 29.4 mg/mL and 37.5+/-30.2 mg/mL, respectively, with a range of 9 to 166 mg/mL. However, total mass of IgG(1) had a median of 209.1g, mean of 291.6+/-315.8 g, and a range of 14 to 2,223 g. Colostrum IgG(1) concentration showed no relationship with colostrum volume, but IgG(1) mass had a positive relationship with volume. Colostrum IgG(1) mass was related to IgG(1) concentration (R(2)=0.58). Using DHIA records for 196 animals, we established milk production for these animals to a 15-d equivalent. An established milk secretion relationship to mammary parenchyma tissue (secretory tissue) was calculated and showed no relationship of IgG(1) mass with mammary parenchyma tissue. In addition, we show that approximately 10% of the sampled animals had IgG(1) mass greater than 1 standard deviation above the mean (high mass transfer) and represented all parities tested (1-7). Whereas first-lactation animals showed less overall calculated parenchyma tissue when compared with other parities, approximately 10% of the first-lactation group animals were capable of high mass transfer, with one transporting 2,029 g into first colostrum. Concentration variance of IgG(1) can be attributed to water inclusion, whereas mass transfer provides a clear indication of animal IgG(1) transfer capacity. The specific mechanism of bovine mammary IgG(1) transfer is not clear, but secretory tissue mass does not explain the variation observed. We hypothesize that the animal variation is attributable to endocrine regulation or genetic variation of the transporter(s).

The objectives of this study were to determine the feasibility of measuring feed intake in commercial tie-stall dairies and infer genetic parameters of feed intake, yield, somatic cell score, milk urea nitrogen, body weight (BW), body condition score (BCS), and linear type traits of Holstein cows. Feed intake, BW, and BCS were measured on 970 cows in 11 Pennsylvania tie-stall herds. Historical test-day data from these cows and 739 herdmates who were contemporaries during earlier lactations were also included. Feed intake was measured by researchers once per month over a 24-h period within 7 d of 6 consecutive Dairy Herd Information test days. Feed samples from each farm were collected monthly on the same day that feed intake was measured and were used to calculate intakes of dry matter, crude protein, and net energy of lactation. Test-day records were analyzed with multiple-trait animal models, and 305-d fat-corrected milk yield, dry matter intake, crude protein intake, net energy of lactation intake, average BW, and average BCS were derived from the test-day models. The 305-d traits were also analyzed with multiple-trait animal models that included a prediction of 40-wk dry matter intake derived from National Research Council equations. Heritability estimates for 305-d intake of dry matter, crude protein, and net energy of lactation ranged from 0.15 to 0.18. Genetic correlations of predicted dry matter intake with 305-d dry matter, crude protein, and net energy of lactation intake were 0.84, 0.90, and 0.94, respectively. Genetic correlations among the 3 intake traits and fat-corrected milk yield, BW, and stature were moderate to high (0.52 to 0.63). Results indicate that feed intake measured in commercial tie-stalls once per month has sufficient accuracy to enable genetic research. High-producing and larger cows were genetically inclined to have higher feed intake. The genetic correlation between observed and predicted intakes was less than unity, indicating potential variation in feed efficiency.

No abstract

The objectives of this study were to calculate the heritability of feed efficiency and residual feed intake, and examine the relationships between feed efficiency and other traits of productive and economic importance. Intake and body measurement data were collected monthly on 970 cows in 11 tie-stall herds for 6 consecutive mo. Measures of efficiency for this study were: dry matter intake efficiency (DMIE), defined as 305-d fat-corrected milk (FCM)/305-d DMI, net energy for lactation efficiency (NELE), defined as 305-d FCM/05-d NEL intake, and crude protein efficiency (CPE), defined as 305-d true protein yield/305-d CP intake. Residual feed intake (RFI) was calculated by regressing daily DMI on daily milk, fat, and protein yields, body weight (BW), daily body condition score (BCS) gain or loss, the interaction between BW and BCS gain or loss, and days in milk (DIM). Data were analyzed with 3- and 4-trait animal models and included 305-d FCM or protein yield, DM, NEL, or CP intake, BW, BCS, BCS change between DIM 1 and 60, milk urea nitrogen, somatic cell score, RFI, or an alternative efficiency measure. Data were analyzed with and without significant covariates for BCS and BCS change between DIM 1 and 60. The average DMIE, NELE, and CPE were 1.61, 0.98, and 0.32, respectively. Heritability of gross feed efficiency was 0.14 for DMIE, 0.18 for NELE, and 0.21 for CPE, and heritability of RFI was 0.01. Body weight and BCS had high and negative correlations with the efficiency traits (-0.64 to -0.70), indicating that larger and fatter cows were less feed efficient than smaller and thinner cows. When BCS covariates were included in the model, cows identified as being highly efficient produced 2.3 kg/d less FCM in early lactation due to less early lactation loss of BCS. Results from this study suggest that selection for higher yield and lower BW will increase feed efficiency, and that body tissue mobilization should be considered.

Colostrum is rich in IGF-I and IGF-II, and the dietary effects of recombinant human (rh)IGF-I on the newborn are of interest. The objective of this study was to examine the effects of dietary rhIGF-I on intestinal tissue growth and populations of IGF receptors. Twenty-three male diary calves were fed one of three experimental diets: 1) milk replacer plus isolated colostrum-derived globulins (MR-), 2) same as 1 plus 750 ng of rhIGF-I/mL (MR+), or 3) pooled cow colostrum (COL). After the first four feedings, all calves received milk replacer without additional globulins; calves fed the MR+ diet continued to receive the addition of 750 ng of rhIGF-I/mL until the experiment ended at 7 d after birth. Calves were killed and intestinal tissue was collected for in vitro [3H]thymidine incorporation studies. Incorporation differed among intestinal regions (duodenum, jejunum, and ileum). The MR+ calves had greater (P < .01) [3H]thymidine incorporation per unit of DNA than either the COL or MR- calves (31.8 vs 18.6 and 11.5 x 10(3) dpm/microgram of DNA, respectively). Competitive binding analysis indicated the presence of specific type 1 and type 2 intestinal IGF receptors. The IGF-I was more potent than IGF-II and insulin at inhibiting [125I]rhIGF-I binding (ED50 was 1.84, 9.17, and 1.91 ng/mL, respectively). The IGF-II was the only ligand capable of inhibiting [125I]rhIGF-II binding (ED50 was .30 nmol/mL).(ABSTRACT TRUNCATED AT 250 WORDS)

To test the hypothesis that insulin-like growth factor I (IGF-I) regulates mammary gland development and lactation, the expression of both human (h) IGF-I and des(1-3)hIGF-I was targeted to the mammary gland in transgenic mice using a novel exon replacement strategy and the rat whey acidic protein (rWAP) gene regulatory sequences. Both transgenes expressed a 0.7-kilobase messenger RNA (mRNA). The abundance of WAP-IGE-I and WAP-DES mRNA on day 10 of lactation ranged from 0.2-1.0% and 0.2-13% of the endogenous mouse WAP mRNA, respectively. For WAP-DES mice, transgene expression was greatest from midpregnancy throughout lactation. Western blot analysis showed the presence of correctly processed hIGF-I in milk from these transgenic mice. This hIGF-I was capable of stimulating protein synthesis in cultured rat L6 myoblasts. Ligand blotting indicated changes in mammary gland secretion of IGFBP in response to WAP-DES expression. Histological analysis of mammary tissue from mice overexpressing des(1-3)hIGF-I showed incomplete mammary involution, ductile hypertrophy, and loss of secretory lobules associated with increased deposition of collagen. These changes are believed to occur through autocrine and paracrine effects of des(1-3)-hIGF-I on both epithelial and stromal cells.

The role of colostrum and milk in the neonate has been chiefly recognized as a comprehensive nutrient foodstuff. In addition, the provision of colostrum-the first milk-for early immune capacity has been well documented for several species. Colostrum is additionally a rich and concentrated source of various factors that demonstrate biological activity in vitro. Three hypotheses have been proposed for the phenotypic function of these secreted bioactive components: (1) only mammary disposal, (2) mammary cell regulation, and (3) neonatal function [gastrointestinal tract (GIT) or systemic]. Traditionally, it was assumed that the development of the GIT is preprogrammed and not influenced by events occurring in the intestinal lumen. However, a large volume of research has demonstrated that colostrum (or milk-borne) bioactive components can basically contribute to the regulation of GIT growth and differentiation, while their role in postnatal development at physiological concentrations has remained elusive. Much of our current understanding is derived from cell culture and laboratory animals, but experimentation with agriculturally important species is taking place. This chapter provides an overview of work conducted primarily in neonatal calves and secondarily in other species on the effects on neonates of selected peptide endocrine factors (hormones, growth factors, in part cytokines) in colostrum. The primary focus will be on insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) and other bioactive peptides, but new interest and concern about steroids (especially estrogens) in milk are considered as well.